General form of registration statement for all companies including face-amount certificate companies

SHAREHOLDERS' EQUITY - Narrative (Details)

v3.23.3
SHAREHOLDERS' EQUITY - Narrative (Details)
 1 Months Ended 12 Months Ended
Mar. 04, 2023
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Nov. 15, 2021
USD ($)
$ / shares
shares
Apr. 30, 2021
USD ($)
shares
Mar. 31, 2023
$ / shares
shares
Jun. 30, 2021
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Jun. 30, 2023
$ / shares
shares
Mar. 03, 2023
$ / shares
shares
Oct. 11, 2022
$ / shares
Sep. 30, 2022
shares
Mar. 03, 2022
shares
Jun. 09, 2021
shares
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                          
Common stock, shares authorized   9,000,000         9,000,000 9,000,000     180,000,000    
Common stock, par value (in dollars per share) | $ / shares   $ 0.001     $ 0.001   $ 0.001 $ 0.001   $ 0.001      
Common stock, shares issued   1,051,098         645,943 5,422,014       22,021,952  
Common stock, shares outstanding   1,051,098         645,943 5,422,014       22,021,952  
Reverse stock split ratio 0.05       0.05                
Fractional shares issued 0       0                
Shares issued     909,262     7,802              
Share price | $ / shares     $ 123.80     $ 80.00              
Shares issue price | $ / shares     $ 105.00                    
Common share purchase warrants per unit                         1
Term of warrants                         48 months
Proceeds from Issuance of Private Placement | $     $ 4,750,000                    
Value of shares issued on settlement of employee compensation | $     $ 435,000                    
Outstanding principal | $             $ 60,000            
Shares issued on conversion of debt             669            
Subsequent Events                          
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                          
Common stock, shares authorized 9,000,000               180,000,000        
Common stock, par value (in dollars per share) | $ / shares $ 0.001               $ 0.001        
Reverse stock split ratio 0.05                        
Fractional shares issued 0                        
Amended Stock Option Plan                          
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                          
Common stock, shares outstanding   42,540           35,870          
Equity Incentive Plan                          
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                          
Common stock, shares outstanding   6,500           11,500          
Number of shares authorized   93,500           88,500          
NervePro                          
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                          
Share issuance, acquisition related (in shares)   75,000                      
Intangible asset | $   $ 390,000                      
Sentry Neuromonitoring, LLC                          
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                          
Value of common stock issuable | $       $ 1,625,000                  
Common stock issuable       11,861                  
Held in escrow, Value | $       $ 650,000                  
Held in escrow, Shares       4,745                  
Common stock lock up period       12 months